A. Kelman

发表

Blood pressure in genetically hypertensive rats. Influence of the Y chromosome.

N. Schork, A. Dominiczak, J. Reid, 1995, Hypertension.

Clinical pharmacokinetics: a comprehensive system for therapeutic drug monitoring and prescribing.

F H Derkx, A W Kelman, A H Thomson, 1984, British medical journal.

Experimental design and efficient parameter estimation in population pharmacokinetics

Brian Whiting, Andrew W. Kelman, A. Kelman, 1990, Journal of Pharmacokinetics and Biopharmaceutics.

Interpretation of Simulation Studies for Efficient Estimation of Population Pharmacokinetic Parameters

E. Ette, A. Kelman, B. Whiting, 1993, The Annals of pharmacotherapy.

Development and validation of a probe allowing accurate and continuous monitoring of location of squamo-columnar junction.

J. Seenan, K. McColl, M. Derakhshan, 2012, Medical engineering & physics.

Kinetics of transient hiatus hernia during transient lower esophageal sphincter relaxations and swallows in healthy subjects

K. McColl, M. Derakhshan, A. Kelman, 2012, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

The prediction of individual systolic time interval v heart rate regression equations.

A. Kelman, B. Whiting, D. Sumner, 1981, British journal of clinical pharmacology.

Variability in the pharmacokinetics of epirubicin: a population analysis

D. Kerr, J. Robert, J. Wade, 2004, Cancer Chemotherapy and Pharmacology.

Evaluation of a Bayesian Approach to the Pharmacokinetic Interpretation of Cyclosporin Concentrations in Renal Allograft Recipients

A W Kelman, A H Thomson, B Whiting, 1994, Therapeutic drug monitoring.

Preliminary experience with a hospital blood pressure follow up clinic with nurse practitioner assessment and microprocessor based data retrieval.

J. Reid, J. Curzio, A. Kelman, 1984, British medical journal.

Pharmacokinetic and pharmacodynamic modelling of trimazosin and its major metabolite

P. Meredith, J. Reid, A. Kelman, 1983, Journal of pharmacokinetics and biopharmaceutics.

Pharmacokinetics of an ACE inhibitor, S-9780, in man: Evidence of tissue binding

J. Reid, K. Lees, A. Kelman, 1989, Journal of Pharmacokinetics and Biopharmaceutics.

Quantification of Ultrasound Emboli Signals in Patients With Cardiac and Carotid Disease

K. Lees, D. Grosset, A. Kelman, 1993, Stroke.

The consequences of H2 receptor antagonist — piroxicam coadministration in patients with joint disorders

C. Howden, A. Kelman, B. Whiting, 2004, European Journal of Clinical Pharmacology.

Hiatus hernia in healthy volunteers is associated with intrasphincteric reflux and cardiac mucosal lengthening without traditional reflux

K. McColl, J. Going, M. Derakhshan, 2016, Gut.

Symptomatic benefit 1–3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease

E. El-Omar, A. Dickson, K. McColl, 2000, American Journal of Gastroenterology.

Pharmacokinetic and pharmacodynamic modelling of the alpha adrenoceptor antagonist doxazosin.

P. Meredith, J. Reid, A. Kelman, 1988, Xenobiotica; the fate of foreign compounds in biological systems.

Modelling the pharmacokinetics and pharmacodynamics of trimazosin.

P. Meredith, J. Reid, A. Kelman, 1986, Biopharmaceutics & drug disposition.

Labetalol disposition and concentration-effect relationships during pregnancy.

J. Reid, A. Kelman, L. Butters, 1983, British journal of clinical pharmacology.

Modelling theophylline response in individual patients with chronic bronchitis.

A. Kelman, B. Whiting, G. Addis, 1981, British journal of clinical pharmacology.

The relationships between dose and concentration of tolbutamide and insulin and glucose responses in patients with non-insulin-dependent diabetes

K. Alberti, M. Rawlins, M. Antsiferov, 1991, European Journal of Clinical Pharmacology.

The effect of captopril on the reflex control heart rate: possible mechanisms.

P. Meredith, J. Reid, B. Campbell, 1985, British journal of clinical pharmacology.

The relationship between steady state metoclopramide levels and control of emesis during treatment with cis-platinum.

D. Kerr, D. Cunningham, S. Kaye, 1985, British journal of clinical pharmacology.

A dose-ranging study of UK-68,798, a novel class III anti-arrhythmic agent, in normal volunteers.

P. Meredith, W. Hillis, A. Kelman, 1991, British journal of clinical pharmacology.

U.K. MRC trial of H. pylori eradication therapy for non-ulcer dyspepsia

L. Murray, R. Knill-Jones, E. El-Omar, 1998 .

Measurement of systolic time intervals.

J. Lawrence, A. Kelman, B. Whiting, 1978, British journal of clinical pharmacology.

Systolic time interval v heart rate regression equations using atropine: reproducibility studies.

A. Kelman, B. Whiting, D. Sumner, 1981, British journal of clinical pharmacology.

Haemodynamic effects of BM 10.188, a new orally active inotropic agent, in healthy volunteers.

W. Hillis, A. Kelman, B. Whiting, 1982, British journal of clinical pharmacology.

Verapamil pharmacokinetics and apparent hepatic and renal blood flow.

P. Meredith, J. Reid, F. Pasanisi, 1985, British journal of clinical pharmacology.

Effect of CGP 17/582, a selective beta-adrenoceptor antagonist, on the haemodynamic and hypokalaemic response to adrenaline.

A. Kelman, J. Reid, K. Whyte, 1989, British journal of clinical pharmacology.

Population Pharmacokinetics of Rectal Theophylline in Neonates

M. Karlsson, A. Thomson, A. Kelman, 1991, Therapeutic drug monitoring.

Compilation of a clinical pharmacokinetic database for population analysis during drug development

A. Kelman, B. Whiting, J. Grevel, 1987 .

Comparison of Helisal Rapid Blood Test and 14C-Urea Breath Test in Determining Helicobacter pylori Status and Predicting Ulcer Disease in Dyspeptic Patients

Mccoll, L. Murray, C. Mowat, 1998, American Journal of Gastroenterology.

Population pharmacokinetics of gentamicin in neonates.

A W Kelman, A H Thomson, B Whiting, 1988, Developmental pharmacology and therapeutics.

Estimation of gentamicin clearance and volume of distribution in neonates and young children.

A W Kelman, A H Thomson, B Whiting, 1984, British journal of clinical pharmacology.

Effect of misspecification of the absorption process on subsequent parameter estimation in population analysis

J. Wade, A. Kelman, B. Whiting, 1993, Journal of Pharmacokinetics and Biopharmaceutics.

Prevalence and Characteristics of Intracranial Microemboli Signals in Patients With Different Types of Prosthetic Cardiac Valves

K. Lees, D. Grosset, A. Kelman, 1994, Stroke.

Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia.

R. Knill-Jones, E. El-Omar, A. Dickson, 1998, The New England journal of medicine.

Central obesity in asymptomatic volunteers is associated with increased intrasphincteric acid reflux and lengthening of the cardiac mucosa.

J. Seenan, S. Hanvey, K. McColl, 2013, Gastroenterology.

Waist belt and central obesity cause partial hiatus hernia and short-segment acid reflux in asymptomatic volunteers

Alexander J. Weir, K. McColl, M. Derakhshan, 2013, Gut.

Effect of nitrite delivered in saliva on postprandial gastro-esophageal function

J. Seenan, K. McColl, M. Derakhshan, 2012, Scandinavian journal of gastroenterology.

Quantitative trait loci in genetically hypertensive rats. Possible sex specificity.

M. Bihoreau, A. Dominiczak, K. Lindpaintner, 1996, Hypertension.

Dietary nitrate generates potentially mutagenic concentrations of nitric oxide at the gastroesophageal junction.

K. McColl, K. Iijima, A. Kelman, 2002, Gastroenterology.

The Helicobacter pylori breath test: a surrogate marker for peptic ulcer disease in dyspeptic patients.

L. Murray, E. El-Omar, K. McColl, 1997, Gut.

The pharmacokinetics and pharmacodynamics of lignocaine and MEGX in healthy subjects

P. Meredith, A. Thomson, A. Kelman, 1987, Journal of Pharmacokinetics and Biopharmaceutics.

Kinetic predictive techniques applied to lignocaine therapeutic drug monitoring.

A W Kelman, B Whiting, W. Hillis, 1983, Therapeutic drug monitoring.

Population Analysis of the Pharmacokinetic Variability of High-Dose Metoclopramide in Cancer Patients

A W Kelman, B Whiting, D N Bateman, 1988, Clinical pharmacokinetics.

Comparison of the electromyographic activity of the muscle orbicularis oris using different electrode configurations.

S. Gatehouse, A. Kelman, 1976, Folia phoniatrica.

Nifedipine: Individual Responses and Concentration‐Effect Relationships

P A Meredith, A W Kelman, P. Meredith, 1988, Hypertension.

Naproxen dose and concentration: response relationship in rheumatoid arthritis.

A. Kelman, B. Whiting, F. Dunagan, 1988, British journal of rheumatology.

Population Pharmacokinetics Theory and Clinical Application

A W Kelman, B Whiting, A. Kelman, 1986, Clinical pharmacokinetics.

The modelling of drug response.

A W Kelman, B Whiting, A. Kelman, 1980, Clinical science.

Randomised trial of endoscopy with testing for Helicobacter pylori compared with non-invasive H pylori testing alone in the management of dyspepsia

L. Murray, C. Mowat, K. McColl, 2002, BMJ : British Medical Journal.

The pharmacokinetics of high dose metoclopramide in patients with neoplastic disease.

A. Kelman, B. Whiting, G. Addis, 1985, British journal of clinical pharmacology.

Pharmacodynamics and population pharmacokinetics of enalapril and lisinopril.

P A Meredith, A W Kelman, P. Meredith, 1985, International journal of clinical pharmacology research.

Evaluation of Six Gentamicin Nomograms Using a Bayesian Parameter Estimation Program

A W Kelman, A H Thomson, A. Thomson, 1990, Therapeutic drug monitoring.

Prediction of response to theophylline in chronic bronchitis.

A W Kelman, B Whiting, A. Struthers, 1984, British journal of clinical pharmacology.

Clinical Decision Making Using Pharmacokinetic and Pharmacodynamic Data

A. Kelman, B. Whiting, 1985 .

Assessment of symptomatic response as predictor ofHelicobacter pylori status following eradication therapy in patients with ulcer

E. El-Omar, K. McColl, A. Kelman, 1998, Gut.

Modeling of drug response in individual subjects

A. Kelman, B. Whiting, 1980, Journal of Pharmacokinetics and Biopharmaceutics.

Evaluation of nonlinear regression with extended least squares: simulation study.

A W Kelman, A H Thomson, B Whiting, 1985, Journal of pharmaceutical sciences.

RELATIONSHIPS DURING PREGNANCY

J. Reid, A. Kelman, P. Rubin, 2006 .

The pharmacokinetics of endralazine in essential hypertensives and in normotensive subjects.

P. Meredith, J. Reid, A. Kelman, 1983, British journal of clinical pharmacology.

Compartmental models and their application

A. W. Kelman, A. Kelman, 1985 .

OPT: a package of computer programs for parameter optimisation in clinical pharmacokinetics.

A W Kelman, B Whiting, S. Bryson, 1982, British journal of clinical pharmacology.

Altered Pharmacokinetics of Cyclosporin in Heart‐Lung Transplant Recipients with Cystic Fibrosis

J. Scott, T. Higenbottam, J. Wallwork, 1990, Therapeutic Drug Monitoring.

Experimental Design and Efficient Parameter Estimation in Preclinical Pharmacokinetic Studies

Ene I. Ette, Brian Whiting, Catherine A. Howie, 1995, Pharmaceutical Research.

Influence of Inter-Animal Variability on the Estimation of Population Pharmacokinetic Parameters in Preclinical Studies

E. Ette, A. Kelman, B. Whiting, 1994 .

Concentration effect modelling with converting enzyme inhibitors in man.

J. Reid, A. Kelman, J. Millar, 1983, British journal of clinical pharmacology.

Simultaneous modelling of pharmacokinetics and pharmacodynamics

Brian Whiting, Andrew W. Kelman, A. Kelman, 1980 .

Quantitation of dose and concentration-effect relationships for fenclofenac in rheumatoid arthritis.

A. Kelman, B. Whiting, F. Dunagan, 1986, British journal of clinical pharmacology.

Assessment of vocal function by air-flow measurements.

M. T. Gordon, A. Kelman, F. M. Morton, 1975, Folia phoniatrica.

Vibratory pattern of the vocal folds.

A W Kelman, A. Kelman, 1981, Folia phoniatrica.

Application of Pharmacokinetic-Pharmacodynamic Modelling for the Comparison of Quinazoline α-Adrenoceptor Agonists in Normotensive Volunteers

P. Meredith, J. Reid, A. Kelman, 1985, Journal of Cardiovascular Pharmacology.

Central obesity in asymptomatic volunteers is associated with increased intrasphincteric acid reflux and lengthening of the cardiac mucosa.

J. Seenan, S. Hanvey, K. McColl, 2013, Gastroenterology.

The pharmacokinetics of mianserin.

A. Kelman, B. Whiting, H. Elliott, 1983, British journal of clinical pharmacology.

RECFIT: a microcomputer-based nonlinear regression curve-fitting package for the quantitative resolution of beta-adrenoceptor subtypes and estimation of nonspecific binding.

G E Trope, B Clark, A W Kelman, 1984, Computers and biomedical research, an international journal.

Analysis of animal pharmacokinetic data: Performance of the one point per animal design

Ene I. Ette, Brian Whiting, Catherine A. Howie, 1995, Journal of Pharmacokinetics and Biopharmaceutics.

Parameter optimisation in clinical pharmacokinetics.

A W Kelman, B Whiting, S. Bryson, 1982, Computer programs in biomedicine.